Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study.

Machielsen MW, Veltman DJ, van den Brink W, de Haan L.

J Psychopharmacol. 2014 Jul;28(7):633-42. doi: 10.1177/0269881114527357. Epub 2014 Mar 19.

PMID:
24646809
2.

Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.

Machielsen MW, Veltman DJ, van den Brink W, de Haan L.

Schizophr Res. 2017 Mar 25. pii: S0920-9964(17)30168-8. doi: 10.1016/j.schres.2017.03.030. [Epub ahead of print]

PMID:
28351544
3.

Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine.

Machielsen M, Beduin AS, Dekker N; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I.

J Psychopharmacol. 2012 Jan;26(1):189-95. doi: 10.1177/0269881111408957. Epub 2011 Jul 18.

PMID:
21768161
4.

Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients.

Molina V, Tamayo P, Montes C, De Luxán A, Martin C, Rivas N, Sancho C, Domínguez-Gil A.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):948-54. doi: 10.1016/j.pnpbp.2007.12.028. Epub 2008 Jan 11.

PMID:
18262704
5.

Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia.

Molina V, Taboada D, Aragüés M, Hernández JA, Sanz-Fuentenebro J.

Schizophr Res. 2014 Sep;158(1-3):223-9. doi: 10.1016/j.schres.2014.06.042. Epub 2014 Aug 1.

PMID:
25088730
6.

LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia.

Tislerova B, Brunovsky M, Horacek J, Novak T, Kopecek M, Mohr P, Krajca V.

Neuropsychobiology. 2008;58(1):1-10. doi: 10.1159/000154474. Epub 2008 Sep 10.

7.

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone.

Green AI, Burgess ES, Dawson R, Zimmet SV, Strous RD.

Schizophr Res. 2003 Mar 1;60(1):81-5.

PMID:
12505141
8.

Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.

Scheltema Beduin AA, Swets M, Machielsen M, Korver N; Genetic Risk and Outcome of Psychosis Investigators.

J Clin Psychiatry. 2012 Nov;73(11):1395-402. doi: 10.4088/JCP.11m07164.

PMID:
23218156
9.

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial.

van Nimwegen LJ, de Haan L, van Beveren NJ, van der Helm M, van den Brink W, Linszen D.

Can J Psychiatry. 2008 Jun;53(6):400-5.

PMID:
18616861
10.

Risperidone response after no clozapine response.

Avnon M, Kunin A.

Br J Psychiatry. 1995 Nov;167(5):699. No abstract available.

PMID:
8564340
11.

Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.

[No authors listed]

Br J Psychiatry Suppl. 1996 Dec;(31):21-30. Review. No abstract available.

PMID:
8968652
12.

Clozapine alone versus clozapine and risperidone with refractory schizophrenia.

Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R; Clozapine and Risperidone Enhancement (CARE) Study Group.

N Engl J Med. 2006 Feb 2;354(5):472-82.

13.

Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.

Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D.

Am J Psychiatry. 1999 Feb;156(2):294-8.

PMID:
9989566
14.

Motivational and control mechanisms underlying adolescent cannabis use disorders: A prospective study.

Cousijn J, van Benthem P, van der Schee E, Spijkerman R.

Dev Cogn Neurosci. 2015 Dec;16:36-45. doi: 10.1016/j.dcn.2015.04.001. Epub 2015 Apr 14.

15.

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

Bondolfi G, Dufour H, Patris M, May JP, Billeter U, Eap CB, Baumann P.

Am J Psychiatry. 1998 Apr;155(4):499-504.

PMID:
9545995
16.

Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.

Wehring HJ, Heishman SJ, McMahon RP, Liu F, Feldman S, Raley H, Weiner E, Kelly DL.

J Dual Diagn. 2017 Jan-Mar;13(1):36-42. doi: 10.1080/15504263.2017.1288946.

17.

A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.

Azorin JM, Spiegel R, Remington G, Vanelle JM, Péré JJ, Giguere M, Bourdeix I.

Am J Psychiatry. 2001 Aug;158(8):1305-13.

PMID:
11481167
18.

Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.

Zink M, Kuwilsky A, Krumm B, Dressing H.

J Psychopharmacol. 2009 May;23(3):305-14. doi: 10.1177/0269881108089593. Epub 2008 Jun 18.

PMID:
18562423
19.

Executive attention impairment in adolescents with schizophrenia who have used cannabis.

Epstein KA, Kumra S.

Schizophr Res. 2014 Aug;157(1-3):48-54. doi: 10.1016/j.schres.2014.04.035. Epub 2014 May 27.

20.

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, Swartz MS, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2006 Apr;163(4):600-10.

PMID:
16585434

Supplemental Content

Support Center